Filtered By:
Condition: Atrial Fibrillation
Education: Academies

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 41 results found since Jan 2013.

Nonvitamin K antagonist oral anticoagulants in everyday practice: Stroke prevention in atrial fibrillation and treatment of venous thromboembolism
ConclusionsAll four NOACs are equivalent to or better than warfarin for the treatment of VTE and stroke prevention in AF, and may reduce the risk of bleeding complications, particularly intracranial bleeding. Implications for practiceNOACs may benefit some patients by avoiding the numerous food or drug interactions and frequent laboratory monitoring associated with warfarin. Adherence to proper dosing is critical for NOAC efficacy and safety.
Source: Journal of the American Academy of Nurse Practitioners - December 17, 2015 Category: Nursing Authors: Barbara A. Bentz Tags: REVIEW Source Type: research

A Review of the Current Literature and Updates on Embolic Stroke of Undetermined Source (ESUS)
AbstractPurpose of ReviewThe initial ESUS construct presumed that atrial fibrillation (AF) would be detected in a substantial percentage of patients, but subsequent studies have determined that the rate of AF detection is much lower than anticipated, thereby highlighting other potential causes of ESUS. To date, there is no clear consensus supporting PFO closure or anticoagulation in ESUS patients. In this review, we discuss the recent studies on potential causes of ESUS and related work-up as well as report the recent trials on the treatment of ESUS.Recent FindingsSome of the potential causes of ESUS are undetected AF, pat...
Source: Current Treatment Options in Neurology - August 6, 2022 Category: Neurology Source Type: research

Updated Guidelines Issued on Anticoagulation Prophylaxis for Stroke in NVAF (FREE)
By Joe Elia The American Academy of Neurology has issued revised guidelines on preventing stroke in the face of nonvalvular atrial fibrillation (NVAF). The …
Source: Physician's First Watch current issue - February 25, 2014 Category: Primary Care Source Type: news

Acute ischemic stroke treatment using mechanical thrombectomy: A study of 137 patients
Conclusion: MT is safe treatment and equally effective for both AC and PC LVO. With careful patient selection, clinical outcome in PC was comparable to AC despite delayed presentation and higher baseline NIHSS.
Source: Annals of Indian Academy of Neurology - August 10, 2017 Category: Neurology Authors: Rakeshsingh K Singh Vishal Annaji Chafale Rakesh Shyam Lalla Keyurkumar Chandrakantbhai Panchal Anil Pandurang Karapurkar Satish Vasant Khadilkar Pawan K Ojha Yogesh Godge Rakesh K Singh Rajesh Benny Source Type: research

Direct Oral Anticoagulants vs. Warfarin to Prevent Stroke and Embolic Events in Patients with Atrial Fibrillation and CKD.
PMID: 30932459 [PubMed - in process]
Source: American Family Physician - March 31, 2019 Category: Primary Care Authors: Lax JW, Wood R, Jonas CE Tags: Am Fam Physician Source Type: research

The Watchman device for preventing stroke in patients with atrial fibrillation
This article discusses the Watchman device, a left atrial appendage occlusion device that provides an option for patients with contraindications for anticoagulation.
Source: Journal of the American Academy of Physician Assistants - October 1, 2021 Category: Primary Care Tags: Review Article Source Type: research

Stenosis Length and Degree Interact With the Risk of Cerebrovascular Events Related to Internal Carotid Artery Stenosis
Conclusion: We found a statistically insignificant tendency for the ultrasound-measured length of sICAS<70% to be longer than that of sICAS≥70%. Moreover, the ultrasound-measured length of sICAS<90% was significantly longer than that of sICAS 90%. Among patients with sICAS≥70%, the degree and length of stenosis were inversely correlated. Larger studies are needed before a clinical implication can be drawn from these results. Introduction Internal carotid artery stenosis (ICAS) causes around one-fifth of ischemic cerebrovascular stroke and has the highest risk of early stroke recurrence...
Source: Frontiers in Neurology - April 8, 2019 Category: Neurology Source Type: research

Asymptomatic Carotid Stenosis Is Associated With Circadian and Other Variability in Embolus Detection
Conclusions: Embolism associated with asymptomatic carotid stenosis shows circadian variation with highest rates 4–6 h before midday. This corresponds with peak circadian incidence of stroke and other vascular complications. These and ASED Study results show that monitoring frequency, duration, and time of day are important in ES detection. Introduction Transcranial Doppler (TCD) detected microembolism in the ipsilateral middle cerebral artery (MCA) may help stratify the risk of stroke and other arterial disease complications in persons with advanced (≥60%) asymptomatic carotid stenosis. If so, this t...
Source: Frontiers in Neurology - April 15, 2019 Category: Neurology Source Type: research

Study: Medtronic touts increased AF detection with Reveal Linq system
Medtronic (NYSE:MDT) today released 1-year results from a study of patients who experienced a cryptogenic stroke, claiming that its Reveal Linq insertable cardiac monitor was able to detect atrial fibrillation at a greater rate than previously reported in a 2014 clinical trial. Results from the real-world study were presented at the 68th American Academy of Neurology’s annual meeting in Vancouver, Canada. The Reveal Linq device is designed to be implanted beneath the skin on the upper left side of the chest and is indicated for monitoring patients experiencing dizziness, palpitation, fainting or syncope, chest pain ...
Source: Mass Device - April 20, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Clinical Trials Patient Monitoring Medtronic Source Type: news

Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation
ConclusionsSignificant evidence from the PETRO and RE‐LY trials and postmarketing analyses of dabigatran etexilate indicate that this direct thrombin inhibitor is as efficacious as warfarin in ischemic stroke prevention. In fact, the studies found that patients taking dabigatran etexilate had fewer incidences of ischemic stroke and intracranial hemorrhage than those taking warfarin. Risk for major gastrointestinal bleeding appears to be higher than that for warfarin. Implications for practicePatients taking dabigatran etexilate do not require blood work to assess international normalized ratio (INR) levels. Because this ...
Source: Journal of the American Academy of Nurse Practitioners - July 25, 2014 Category: Nursing Authors: Katie A. Scott, Karen A. Amirehsani Tags: CLINICAL PRACTICE Source Type: research

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
DiscussionCurrent guidelines in the treatment of cerebral vein thrombosis dating back to 2011 from the American Heart Association/American Stroke Association endorse the utility of anticoagulation for the treatment of cerebral vein thrombosis; however, they did not support the use of direct oral anticoagulants. Updated guidelines from the European Stroke Organization, endorsed by the European Academy of Neurology in 2017, also refute utilization of direct oral anticoagulants due to a lack of evidence. There have been nearly 10  years of experience with direct oral anticoagulants in the treatment of venous thrombosis and ...
Source: Systematic Reviews - April 17, 2019 Category: International Medicine & Public Health Source Type: research

Blood Thinners Now Recommended for People with Irregular Heartbeat
Updated guideline from American Academy of Neurology aims to reduce stroke risk Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Stroke
Source: MedlinePlus Health News - February 24, 2014 Category: Consumer Health News Source Type: news

Clinical correlates of leukoaraiosis: A study of 175 patients
This study was designed to investigate the factors which correlate with LA. Materials and Methods: We included patients with LA who consented for the study and graded their severity on the basis of Fazekas scale. We excluded patients with LA who did not consent/cooperate for the study as also patients with other white matter changes which mimic LA. Results: LA is a common and under-rated cause of disability. Presentations include cognitive decline, gait disturbance, dysarthria, bladder/bowel sphincter disturbances, and increased risk of stroke. The comorbidities include hyperhomocysteinemia, hypertension, dyslipidemia, tob...
Source: Annals of Indian Academy of Neurology - November 21, 2016 Category: Neurology Authors: Rustom S Wadia Sandesh K Ghiya Joshita Singh Santosh M Sontakke Vishwas Bharadwaj Rahul V Sonawane Yogesh P Bade K Shrikanth Nikhil Goli Rohit Singh Chauhan Nilesh A Nadkarni Source Type: research

Review: New Oral Anticoagulants for Afib, VTE, and ACSReview: New Oral Anticoagulants for Afib, VTE, and ACS
A review focused on the new oral anticoagulants for stroke prophylaxis in patients with atrial fibrillation, venous thromboembolism (VTE), and acute coronary syndrome (ACS). American Academy of Emergency Medicine
Source: Medscape Emergency Medicine Headlines - May 30, 2013 Category: Emergency Medicine Tags: Emergency Medicine Article Source Type: news

Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation: Report of the Guideline Development Subcommittee of the American Academy of Neurology
Source: Neurology - April 21, 2014 Category: Neurology Tags: CORRECTIONS Source Type: research